Hexigone Inhibitors
PrivateLast Round
Grant
Jun 2, 2026
Total Funding Raised
$2.54M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Hexigone Inhibitors operates in Frontier & Industrial Tech and is based in Port Talbot. Its latest recorded funding round was a Grant round in June 2026.
Hexigone Inhibitors is an industrial chemicals company that develops and manufactures smart, sustainable anti-corrosion additives for the coatings industry.
Sector
Frontier & Industrial Tech
Verticals
Advanced Materials, Sustainable Materials, Circular Economy, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hexigone Inhibitors Comparables
Compare Hexigone Inhibitors with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SynMatter | 79% | |
| Grace Inc. | 77% | |
| ICL Group | 76% |
For institutional investors. Book with your work email.
Hexigone Inhibitors Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 2, 2026 | ||||
| Seed | Jun 2, 2026 | ||||
| VC Round | Apr 30, 2024 | ||||
| Grant | Oct 28, 2019 | ||||
| Debt | Feb 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hexigone Inhibitors Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACF Investors | VC Round |
| Royal Society of Chemistry | Grant |
| UK Innovation & Science Seed Fund | Seed |
| Royal Academy of Engineering | Grant |
| Waterspring Ventures | VC Round |
| Oxford Innovation Finance | VC Round |
| Development Bank of Wales | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 186% MoM, reaching 1.7K.
- Jun 2, 2026
Raised $540K in grant funding.
For institutional investors. Book with your work email.
Hexigone Inhibitors Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hexigone Inhibitors's valuation, stock price, and market status.
Is Hexigone Inhibitors a public or private company?
Hexigone Inhibitors is a private company.
What is the current stock price of Hexigone Inhibitors?
Hexigone Inhibitors is a private company, so its shares have no public market price. Caplight tracks Hexigone Inhibitors's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hexigone Inhibitors worth (valuation)?
Valuation information for Hexigone Inhibitors is not publicly available.
Can I buy Hexigone Inhibitors stock?
Hexigone Inhibitors shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hexigone Inhibitors's last funding round?
Hexigone Inhibitors's most recent funding round was Grant on June 2, 2026.
Who are the main investors in Hexigone Inhibitors?
Key investors in Hexigone Inhibitors include UK Innovation & Science Seed Fund.
Will Hexigone Inhibitors IPO soon?
No public IPO plans have been announced for Hexigone Inhibitors.
How can I track Hexigone Inhibitors secondary market activity?
Caplight tracks bids, offers, and trades in Hexigone Inhibitors's shares on secondary markets.